Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2010-05-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Cognitive Function
NCT04184388
Safety for 24 Weeks Intake of Korean Red Ginseng in Adults
NCT02428998
Effects of Korean Red Ginseng Extract on Electrical Brain Activity in Elderly Subjects
NCT04167449
Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension
NCT02211352
Efficacy and Safety of Red Ginseng on Decrement of Body Fat
NCT01734005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Korean Red Ginseng
Korean Red Ginseng
Korean Red Ginseng Capsule (1g/day) for 8 Weeks
Placebo
Placebo
Placebo Capsule (1g/day) for 8 Weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Korean Red Ginseng
Korean Red Ginseng Capsule (1g/day) for 8 Weeks
Placebo
Placebo Capsule (1g/day) for 8 Weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Current Axis 1 diagnosis or past history of schizophrenia, bipolar, or psychotic disorders assessed by SCID-IV
* Current diagnosis of substance abuse assessed by SCID-IV
* Taking or have taken psychiatric medication in the past 2 months
* Head trauma accompanied by loss of consciousness or seizure
* IQ 80 or below
* Planning pregnancy, currently pregnant, or breastfeeding
* Claustrophobia or other fMRI incompatible factors such as pace makers
* Taking drugs, including over the counter drugs
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
In Kyoon Lyoo, MD, PhD, MMS
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
In Kyoon Lyoo, MD, PhD, MMS
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KG2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.